Reply to "Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit"

Ann Surg. 2017 Apr;265(4):e42-e43. doi: 10.1097/SLA.0000000000001197.

Authors

A Koen Talsma¹, Bas P L Wijnhoven, Ewout W Steyerberg, J Jan B van Lanschot

Affiliation

¹ Department of Surgery, Erasmus-MC Medical Center, Rotterdam, The Netherlands Department of Surgery, Erasmus-MC Medical Center, Rotterdam, The Netherlands Department of Public Health, Erasmus-MC Medical Center, Rotterdam, The Netherlands Department of Surgery, Erasmus-MC Medical Center, Rotterdam, The Netherlands.

PMID: 28266983
DOI: 10.1097/SLA.0000000000001197

No abstract available

Publication types

Letter
Comment

MeSH terms

Esophageal Neoplasms*
Esophagectomy
Humans
Lymph Node Excision
Neoadjuvant Therapy*